Clinical Trial Update: PTC124 for the Treatment of Cystic Fibrosis [Phase 2]

View source ↗

Summary

PTC Therapeutics reports the Phase 2 trial of PTC124 (ataluren) for cystic fibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• PTC124 (ataluren)

Snippet

Sponsor: PTC Therapeutics | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED